New compound is effective against drug-resistant leukemia, preclinical study finds
Friday, March 18, 2016 - 20:50
in Health & Medicine
A novel compound MRX-2843 more than doubled the median days of survival in laboratory models with a drug-resistant form of the acute myeloid leukemia, scientists report in a new article.